Climate Performance, Environmental Toxins and Nutrient Density of the Underutilized Norwegian Orange-Footed Sea Cucumber (Cucumaria frondosa)

Low trophic species are often mentioned as additional food sources to achieve broader and more sustainable utilisation of the ocean. The aim of this study was to map the food potential of Norwegian orange-footed sea cucumber (Cucumaria frondosa). C. frondosa contained 7% protein, 1% lipids with a high proportion of polyunsaturated fatty acids, and a variety of micronutrients. The nutrient density scores (NDS) of C. frondosa were above average compared towards daily recommended intakes (DRI) for men and women (age 31–60) but below when capped at 100% of DRI. The concentrations of persistent organic pollutants and trace elements were in general low, except for inorganic arsenic (iAs) (0.73 mg per kg) which exceeded the limits deemed safe by food authorities. However, the small number of samples analysed for iAs lowers the ability to draw a firm conclusion. The carbon footprint from a value chain with a dredge fishery, processing in Norway and retail in Asia was assessed to 8 kg carbon dioxide equivalent (CO2eq.) per kg C. frondosa, the fishery causing 90%. Although, C. frondosa has some nutritional benefits, the carbon footprint or possible content of iAs may restrict the consumption.Climate Performance, Environmental Toxins and Nutrient Density of the Underutilized Norwegian Orange-Footed Sea Cucumber (Cucumaria frondosa)publishedVersio

A cross-sectional comparison of performance, neurophysiological and MRI outcomes of responders and non-responders to fampridine treatment in multiple sclerosis - An explorative study

OBJECTIVE: To compare baseline physical and cognitive performance, neurophysiological, and magnetic resonance imaging (MRI) outcomes and examinetheir interrelationship inparticipants with Multiple Sclerosis (MS), already established aseither responder or non-responder to Fampridine treatment, andto examine associationswiththe expanded disability status scale (EDSS) and 12-item MS walking scale (MSWS-12). METHODS: Baseline data from an explorative longitudinal observational study were analyzed. Participants underwent the Timed 25-Foot Walk Test (T25FW), Six Spot Step Test (SSST), Nine-Hole Peg Test, Five Times Sit-to-Stand Test, Symbol Digit Modalities Test (SDMT), neurophysiological testing, including central motor conduction time (CMCT), peripheral motor conduction time (PMCT), motor evoked potential (MEP) amplitudesand electroneuronographyof the lower extremities, and brain MRI (brain volume, number and volume of T2-weighted lesions and lesion load normalized to brain volume). RESULTS: 41 responders and 8 non-responders were examined. There were no intergroup differences inphysical performance, cognitive, neurophysiological, andMRI outcomes (p > 0.05).CMCT was associated withT25FW, SSST, EDSS, and MSWS-12,(p < 0.05). SDMT was associated with the number and volume of T2-weighted lesions, and lesion load normalized to brain volume (p < 0.05). CONCLUSION: No differences were identified between responders and non-responders to Fampridine treatment regarding physical and cognitive performance, neurophysiological or MRI outcomes. The results call for cautious interpretation and further large-scale studies are needed to expand ourunderstanding of underlying mechanisms discriminating Fampridine responders and non-responders.CMCT may be used as a marker of disability and walking impairment, while SDMT was associated with white matter lesions estimated by MRI. ClinicalTrials.gov identifier: NCT03401307

NKS ICP User 2017 Seminar Proceedings

The ICP User seminar was held at Risø, Denmark, during 25-27 September 2017. The seminar consisted of 2-day lectures given by six invited professionals and thirteen seminar participants, as well as 1-day lab training by invited expert. The lectures covered different topics including theoretical principles of ICP, methodology development and application of ICP techniques for different isotopes/isotopic ratios, recent development of new ICP technology and its application, etc. The results obtained from the inter-comparison exercise 2016 were presented and discussed. The lab training covered demonstration of the operation of ICP-MS, software and technical instructions. The seminar was attended by 51 individuals from 26 organisations

An inter-comparison exercise on the application of ICP-MS techniques for measurement of long-lived radionuclides

Inductively coupled plasma (ICP) spectrometry techniques are widely used in the fields related to environmental monitoring, nuclear waste disposal and management, radioecology and tracer studies, as well as nuclear forensics and nuclear emergency preparedness. Especially ICP mass spectrometry (ICP-MS) is playing an important role for determination of low-level long-lived radionuclides and their isotopic ratios. ICP optical emission spectrometry (ICP-OES) is commonly used for determining stable elements (Al, Fe, Ca, etc.) and cannot perform isotopic ratio measurement with desirable precision and at low analyte concentrations. Therefore ICP-OES is often used as a supplementary technique to ICP-MS in the analysis, for instance, to screen the matrix composition of a sample, or to determine Sr and Y chemical yield in the Sr-90 analysis, etc. Among the Nordic countries, there are probably less than 20 ICP-MS instruments which are currently applied in the nuclear field for the measurement of radionuclides and their isotopic ratios. Due to different application purposes and technical background of the analysts, each ICP lab has different set-ups and experiences in running these instruments. More efficient application of ICP-MS will be achieved when these experiences are well shared among these labs. Also, for newly established ICP labs or scientists/students in the Nordic countries to quickly build up the competence in operating their instruments in practice, hands-on experience is very valuable. Therefore, within the Nordic-ICP project, an inter-comparison exercise was performed during 2016, which was focused on the measurement of uranium and plutonium isotopes in certified reference material by ICP-MS in combination with radiochemical separation. This report summarizes the results and conclusions obtained base on this inter-comparison exercise

Neodymium-140 DOTA-LM3:Evaluation of an <i>In Vivo</i> Generator for PET with a Non-Internalizing Vector

140Nd (t1/2 = 3.4 days), owing to its short-lived positron emitting daughter 140Pr (t1/2 = 3.4 min), has promise as an in vivo generator for positron emission tomography (PET). However, the electron capture decay of 140Nd is chemically disruptive to macrocycle-based radiolabeling, meaning that an in vivo redistribution of the daughter 140Pr is expected before positron emission. The purpose of this study was to determine how the delayed positron from the de-labeled 140Pr affects preclinical imaging with 140Nd. To explore the effect, 140Nd was produced at CERN-ISOLDE, reacted with the somatostatin analogue, DOTA-LM3 (1,4,7,10- tetraazacyclododecane, 1,4,7- tri acetic acid, 10- acetamide N - p-Cl-Phecyclo(d-Cys-Tyr-d-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)d-Tyr-NH2) and injected into H727 xenograft bearing mice. Comparative pre- and post-mortem PET imaging at 16 h postinjection was used to quantify the in vivo redistribution of 140Pr following 140Nd decay. The somatostatin receptor-positive pancreas exhibited the highest tissue accumulation of 140Nd-DOTA-LM3 (13% ID/g at 16 h) coupled with the largest observed redistribution rate, where 56 ± 7% (n = 4, mean ± SD) of the in situ produced 140Pr washed out of the pancreas before decay. Contrastingly, the liver, spleen, and lungs acted as strong sink organs for free 140Pr3+. Based upon these results, we conclude that 140Nd imaging with a non-internalizing vector convolutes the biodistribution of the tracer with the accumulation pattern of free 140Pr. This redistribution phenomenon may show promise as a probe of the cellular interaction with the vector, such as in determining tissue dependent internalization behavior

Kartlegging av radioaktive stoffer i Oslofjorden

Prosjektleder: Anders RuusDSA har ønsket å undersøke om utslipp av radioaktive stoffer fra helsesektoren kan gjenfinnes i miljøet og om I-131 tas opp og/eller oppkonsentrerer i Oslofjorden. Det ble ikke funnet I-131 eller Tc-99m i biota i detekterbare mengder. Dette tyder på lavt opptak, og liten tilknyttet risiko for organismer i Oslofjorden. Lave konsentrasjoner av Tc-99m og I-131 ble målt i noen vannprøver, samt I-131 i noen sediment prøver. Lu-177 ble ikke detektert i noen prøver. Disse observasjonene er ikke i konflikt med strømningsmønsteret i området, men partiklene skal også rekke å sedimentere til bunnen, tidsnok til at deteksjon er mulig (I-131 har halveringstid på 8 døgn). Selv med fordeling av prøvene over fire ulike prøveinnsamlingstidspunkter ble det for lang tid mellom prøvetaking og måling, med så lave konsentrasjoner av kortlevde radionuklider. Med så lave nivåer må man i fremtiden ta sikte på færre prøver og enda kortere tid mellom prøvesamling og måling, kanskje ved å fokusere på et mindre geografisk område. Resultatene gir et innblikk i situasjonen før en forventet økning i bruk av nukleærmedisin ved sykehusene.Direktoratet for strålevern og atomsikkerhet (DSA)publishedVersio